Table 3 Sum of the total tumour size and distribution of metastases in all patients

From: Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients

Product of diameters

 

 Median (range)

154 mm2(15–20 976)

Site of metastases

 

 Lung

163 (29%)

 Liver

86 (15%)

 Other solid organs

27 (5%)

 Peritoneal

51 (9%)

 Node

140 (25%)

 Subcutaneous

53 (9%)

 Other

47 (8%)